These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7084696

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ocular effects of treatment with various psoralen derivatives and ultraviolet-A (UVA) radiation in HRA/Skh hairless mice.
    Barker FM, Dayhaw-Barker P, Forbes PD, Davies RE.
    Acta Ophthalmol (Copenh); 1986 Aug; 64(4):471-8. PubMed ID: 3776510
    [Abstract] [Full Text] [Related]

  • 3. Photochemotherapy and the eye: photoprotective factors.
    Glew WB, McKeever G, Roberts WP, Malinin G, Nigra TP.
    Trans Am Ophthalmol Soc; 1980 Aug; 78():243-54. PubMed ID: 7257058
    [Abstract] [Full Text] [Related]

  • 4. Psoralen--long-wave ultraviolet therapy and human cataractogenesis.
    Lerman S, Megaw J, Gardner K.
    Invest Ophthalmol Vis Sci; 1982 Dec; 23(6):801-4. PubMed ID: 7141823
    [Abstract] [Full Text] [Related]

  • 5. [PUVA treatment and the problem of ocular damage (author's transl)].
    Lerman S, Koch HR.
    Klin Monbl Augenheilkd; 1981 May; 178(5):347-9. PubMed ID: 7253523
    [Abstract] [Full Text] [Related]

  • 6. Histologic observations of the lenses of psoralen + UVA treated albino rats and a theory as to the underlying mechanism.
    Jose JG, Koch HR, Respondek A.
    Graefes Arch Clin Exp Ophthalmol; 1982 May; 219(1):44-53. PubMed ID: 7117861
    [Abstract] [Full Text] [Related]

  • 7. Psoralens and ocular effects in man and animals: in vivo monitoring of human ocular and cutaneous manifestations.
    Lerman S.
    Natl Cancer Inst Monogr; 1984 Dec; 66():227-33. PubMed ID: 6531035
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lens opacities appearing during therapy with methoxsalen and long-wavelength ultraviolet radiation.
    Lafond G, Roy PE, Grenier R.
    Can J Ophthalmol; 1984 Jun; 19(4):173-5. PubMed ID: 6744101
    [Abstract] [Full Text] [Related]

  • 14. Molecular aspects of extracorporeal photochemotherapy.
    Gasparro FP, Dall'Amico R, Goldminz D, Simmons E, Weingold D.
    Yale J Biol Med; 1989 Jun; 62(6):579-93. PubMed ID: 2700057
    [Abstract] [Full Text] [Related]

  • 15. Neoplastic transformation of C3H mouse embryo 10T1/2 cells by 8-methoxypsoralen plus UVA radiation.
    Ananthaswamy HN.
    J Invest Dermatol; 1985 Aug; 85(2):102-6. PubMed ID: 4020157
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ocular findings in patients treated with PUVA.
    Stern RS, Parrish JA, Fitzpatrick TB.
    J Invest Dermatol; 1985 Sep; 85(3):269-73. PubMed ID: 4031542
    [Abstract] [Full Text] [Related]

  • 20. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
    Calzavara-Pinton PG, Zane C, Carlino A, De Panfilis G.
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.